ArticleLeukemia2015

Mesenchymal stromal cells infusions improve refractory chronic graft versus host disease through an increase of CD5+ regulatory B cells producing interleukin 10.

Y Peng et al.PubMed ↗Publisher ↗

No numbers read from the abstract.